Spitzenleistung neu definiert

Der MICRORAPTOR KNOTLESS Fadenanker ermöglicht Operateuren einen besseren Zugang zu bislang schwer erreichbaren Bereichen mit verbesserter Performance bei achsenversetzter Einbringung,*1 einem Inserter, welcher den Anker über die komplette Länge stützt, und stabilem Implantatdesign.

Education

No results.

Disclaimers

*As demonstrated in benchtop testing, compared to Arthrex PushLockTM BioComposite 2.9 mm.

**Compared to Arthrex PushLockTM PEEK Suture Anchor and Stryker CinchLockTM SS Knotless Anchor.

***As demonstrated in benchtop testing; compared to Arthrex BioComposite PushlockTM 2.9 mm, Arthrex BioComposite PushlockTM 2.9 mm Short and Stryker CinchLock Knotless; p<0.001.

****Demonstrated in vitro.

*****Demonstrated clinically and in vivo.

Most biocomposite materials rely solely on the osteoconductive properties of ß-TCP.9,10 REGENESORB material contains two osteoconductive components – ß-TCP and calcium sulfate – which act during different stages in the bone healing process and Through different mechanisms of action, physical and biochemical. REGENESORB Material is unique in this regard. No other biocomposite material can claim this.11-13

Citations
  1. Smith+Nephew 2019. Internal report. 15008464 Revision A.
  2. Smith+Nephew 2019. Internal report. 15008252 Revision A.
  3. Smith+Nephew 2019. Internal report. 15008255 Revision A.
  4. Vonhoegen J, et al. Orthop Traumatol Surg Res. 2019;14(1):12.
  5. Smith+Nephew 2010. Internal report. WRP-TE045-700-08.
  6. Smith+Nephew 2016. Internal report. NCS248
  7. Smith+Nephew 2019. Internal report. 15007134.
  8. Smith+Nephew 2019. Internal report. 15007045.
  9. Constantino, F. Otolaryngol Clin North Am. 1994 27(5):1037-1074.
  10. Ogose A, et al. J Biomed Mater Res B Appl Biomater. 2005;72(1):94-101
  11. Allison DC, et al. US Oncology and Hematolog. 2011.
  12. Walsh WR, et al. Clin Orthop Relat Res. 2003(406):228-236.
  13. Ogose A, et al. Biomaterials. 2006;27(8):1542-1549.

Title

Text